Results 41 to 50 of about 1,825 (197)
Macrophage‐Targeting Biomaterials for Osteoarthritis Therapy
Journal of Biomedical Materials Research Part A, Volume 114, Issue 5, May 2026.Macrophage‐Targeting Biomaterials for Osteoarthritis Therapy. Created in BioRender. Jain, E. (2026) https://BioRender.com/x4f9o8g. ABSTRACT Osteoarthritis (OA) is a highly prevalent, disabling, and painful disease of the joints, characterized by progressive cartilage degeneration, synovial fibrosis, and pain.
Era Jain, Paul Nana Kwame Sagoe
wiley +1 more source
Journal of Anaesthesiology Clinical Pharmacology, 2013 Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are valuable for post-operative pain as they reduce the use of opioids. Cyclooxygenase-2 inhibitors and traditional NSAIDs can be used. This is a prospective, randomized, placebo-controlled trial
Irene Kouroukli +5 more
doaj +1 more source
A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms [PDF]
Chemical Industry and Chemical Engineering Quarterly, 2014 A new method for the simultaneous determination of paracetamol (PR) and lornoxicam (LR) has been developed by reversed phase HPLC from the combination drug product.
Karunakaran Kulandaivelu +2 more
doaj +1 more source
Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk [PDF]
Терапевтический архив, 2019 The review presents current information on the role of NSAIDs in the development of cardiovascular disasters. The development of non-desirable cardiovascular effects and an increase in cardiovascular risk with the administration of NSAIDs, most experts ...
A V Naumov, O N Tkacheva, N O Khovasova
doaj +1 more source
Cutaneous Pseudolymphoma Following Administration of Lornoxicam
Acta Dermato-Venereologica, 2007 Since aspirin was introduced over a century ago, many new anti-inflammatory agents have been marketed. NSAIDs are currently the most commonly prescribed agents in Western medicine (1). Their widespread use has resulted in a number of well-documented adverse reactions. These most frequently involve the gastro-intestinal tract, causing discomfort, nausea
Stavrianeas, N.G. +7 more
openaire +3 more sources
Mass spectrometry in ocular drug research
Mass Spectrometry Reviews, Volume 45, Issue 1, Page 37-68, January/February 2026.Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo +6 more
wiley +1 more source
Physicochemical characterization of lornoxicam gels F1-F9 (n = 3).
, 2020 Physicochemical characterization of lornoxicam gels F1-F9 (n = 3).
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source
Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis [PDF]
Iranian Journal of Basic Medical Sciences, 2014 Objective(s): The aim of present research was to develop matrix-mini-tablets of lornoxicam filled in capsule for targeting early morning peak symptoms of rheumatoid arthritis.
Abdul Hadi Mohd +2 more
doaj
Molecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.This study evaluated pharmacogenomic (PGx) calling from whole‐exome sequencing (WES) in 3562 Taiwanese individuals. Fourteen pharmacogenes were reliably identified, with each person carrying an average of ~2.4 actionable phenotypes. The high actionable frequencies of G6PD deficiency and HLA‐B*58:01 highlight ethnic differences and support WES as a ...
Hsu‐Heng Lin +9 more
wiley +1 more source
Composition of lornoxicam gel for membrane-based transdermal patches.
, 2020 Composition of lornoxicam gel for membrane-based transdermal patches.
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source